Neurovascular Market Segmentation, Analysis and Forecast 2020

1
Neurovascular Market Demand and Forecast 2020
2
SYNOPSIS
The report provides market analysis, information
and insights into Neurovascular Market Demand
and Forecast 2020 About Neurovascular
Condition Neurovascular disease is a condition
caused to nervous tissues vascular structure,
neurons and blood vessels that leads to serious
brain damages such as stroke, and cerebral
hemorrhage. The global market for central nervous
system disease was accounted to approximately 78
billion in 2010. Neurovascular disease market is
mainly driven by the increase in number of
patients suffering from neurological diseases.
According to University of California, San
Francisco (USCF), there are approximately 600,000
people suffering from stroke, out of which 10
are recovered. Almost 30 patients die due to
stroke, and 60 of the patients remain disabled.
View more details _at_ http//www.bigmarketresearch
.com/neurovascular-market
3
KEY MARKET BENEFITS  

• This report offers the following benefits in
  particular
• Key developmental strategies adopted by top
  market players engaged in this business, so that
  companies involved in development of
  neurovascular device can get competitive
  intelligence of their competitors
• Market estimation for therapeutic devices and
  geographic segment is derived from current market
  scenario and expected market trends
• Market attractiveness analysis has been included
  for various product segments, therapeutics,
  devices and geographic regions with detailed
  analysis of factors responsible for rapid growth
  of the market segments
• In depth analysis of key market drivers,
  restraints and opportunities of non-invasive
  diagnostic market with impact analysis
• Value chain analysis, Porters five force model,
  top investment pockets (GE9 Cell Matrix) are
  analyzed and presented in detail in the report so
  that the decision makers receive clear picture of
  neurovascular disease treatment market

4
KEY MARKET SEGMENTS
Neurovascular Market is segmented based on , by
therapeutics, devices and geography. GLOBAL
MARKET, BY THERAPEUTICS   Endovascular
cerebral aneurysm Intracranial atherosclerotic
disease Chronic ischemic stroke Acute
ischemic stroke   GLOBAL MARKET, BY
DEVICES   Neurovascular liquid
embolism Intracranial stents flow diverting
devices Neurovascular embolic coils Carotid
stents embolic protection devices Neurovascula
r thrombectomy devices .
5
MARKET OVERVIEW
The cost of care for these 60 patients accounted
to approximately 8 billion. Cost of neurological
disease treatment is lowering the growth for
neurological disease. Companies are conducting
clinical trials to commercialized cost effective
therapies through mergers and acquisitions. Medica
l device manufacturing companies are facing
challenges in the form of commercialization in
developing countries such as India, China, and
Malaysia. However, increase in research on
neurovascular therapies, and favorable government
policies, would give the necessary push to the
neurovascular market.   This report gives
intelligence about current market trends
available and transition of these trends in
future. Market intelligence of key patents
granted by respective authorities is provided in
this report.
6
SUMMARY
The key companies included in this report are
Medtronic, Stryker, Covidien (Ev3) , Johnson
Johnson (Micrus), Abbott Laboratories, Bayer AG,
Boston Scientific Corporation, Cardiatis, S.A.,
Chestnut Medical Technologies, Inc., Johnson
Johnson, ITGI Medical Ltd.   KEY
AUDIENCES   Medical device manufacturing
companies Research based pharmaceutical
companies Academic Institutes Government and
Private research laboratories Enquire About
Report _at_ http//www.bigmarketresearch.com/report-e
nquiry/22700  
7
CONTACT US
Big Market Research Deep Joshi 5933 NE Win
Sivers Drive, 205, Portland, OR 97220 United
States Direct 1-503-894-6022 Toll Free
1-800-910-6452 Fax [phone] Email
help_at_bigmarketresearch.com Web
http//www.bigmarketresearch.com